Imexpharm Corp (IMP) — Free Cash Flow Generation Index
Imexpharm Corp (IMP) has a Free Cash Flow Generation Index of 0.70x as of June 2026. Free cash flow of ₫38.85 Billion represents 1% of operating cash flow (₫55.75 Billion). Explore IMP capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Imexpharm Corp Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Imexpharm Corp across 6 annual periods. For the full cash flow conversion analysis, see Imexpharm Corp cash flow conversion.
Annual Free Cash Flow Generation for Imexpharm Corp (2019–2025)
Year-by-year Free Cash Flow Generation Index for Imexpharm Corp. Check Imexpharm Corp total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (VND) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | ₫27.29 Billion | ₫54.17 Billion | ₫26.88 Billion | ▼ -8.8% |
| 2024 | 0.55x | ₫119.50 Billion | ₫216.27 Billion | ₫96.77 Billion | ▼ -25.1% |
| 2022 | 0.74x | ₫279.25 Billion | ₫378.60 Billion | ₫99.35 Billion | ▼ -4.8% |
| 2021 | 0.77x | ₫182.02 Billion | ₫234.88 Billion | ₫52.86 Billion | ▲ +442.9% |
| 2020 | -0.23x | ₫-16.53 Billion | ₫73.15 Billion | ₫89.68 Billion | ▲ +76.7% |
| 2019 | -0.97x | ₫-64.53 Billion | ₫66.59 Billion | ₫131.12 Billion | — |